Search results
Order by most recent / most popular / relevance
Results: 1-10 of 34
FDA finalizes guidance to address potential bias and conflicts of interest in clinical investigations
- Sidley Austin LLP
- -
- USA
- -
- March 1 2013
FDA has finalized its guidance on financial disclosure for clinical investigators. A draft of the guidance, published in May 2011, was developed in
Increased FDA scrutiny of pre-approval communications continued in 2012
- Sidley Austin LLP
- -
- USA
- -
- February 5 2013
Warning and untitled letters issued to prescription drug manufacturers in 2012 reflect continued FDA focus on pre-approval communications. FDA's
FDA proposes two groundbreaking food safety rules
- Sidley Austin LLP
- -
- USA
- -
- January 8 2013
On January 4, 2013, the U.S. Food and Drug Administration ("FDA" or the "Agency") proposed two major, long-awaited rulemakings required by the Food Safety
FDA releases draft guidance concerning clinical trials
- Sidley Austin LLP
- -
- USA
- -
- December 6 2012
On November 20, the Food and Drug Administration (FDA) took another step toward modernizing clinical trial oversight by issuing two draft guidance documents related to the conduct of clinical trials
Second Circuit rejects FDA regulation of “off-label” promotion as misbranding in Caronia case
- Sidley Austin LLP
- -
- USA
- -
- December 3 2012
In a widely anticipated ruling, the United States Court of Appeals for the Second Circuit this morning reversed the conviction of pharmaceutical sales representative Alfred Caronia for misbranding under the Federal Food, Drug, and Cosmetic Act (FDCA), based on alleged “off-label” promotion
FDA issues warning letter to Lancôme for anti-aging claims
- Sidley Austin LLP
- -
- USA
- -
- September 14 2012
On September 7, 2012, the compliance office within the Center for Food Safety and Applied Nutrition (CFSAN) at FDA issued a Warning Letter to Lancôme USA, a subsidiary of L’Oréal, regarding several anti-aging skin care products being marketed as cosmetics
New Chinese medical device GCP unveiled for public comments
- Sidley Austin LLP
- -
- China
- -
- September 4 2012
The Chinese State Food and Drug Administration (“SFDA”) published the revised Medical Device Good Clinical Practice (“Medical Device GCP”) in late August and is soliciting public comments until September 30, 2012
Stem cell warning letter reflects FDA focus on medical procedures
- Sidley Austin LLP
- -
- USA
- -
- April 9 2012
On March 13, 2012, the compliance office within the Center for Biologics Evaluation and Research (CBER) at FDA sent a Warning Letter to IntelliCell Biosciences, Inc., alleging that the firm’s IntelliCell process, based on acquiring adipose-derived stem cells and resulting in stromal vascular fraction, is a biological drug regulated under the Federal Food, Drug, and Cosmetic Act
Draft guidance on DTC ad pre-review program
- Sidley Austin LLP
- -
- USA
- -
- March 14 2012
On March 13, FDA released a draft guidance on pre-dissemination review of direct-to-consumer (DTC) television ads for prescription drugs, implementing FDCA 503B, added by Section 901(d)(2) of the FDA Amendments Act of 2007 (FDAAA), codified at 21 U.S.C. 353b (“The Secretary may require the submission of any television advertisement for a drug (including any script, story board, rough, or a completed video production of the television advertisement) to the Secretary for review under this section not later than 45 days before dissemination of the television advertisement”
FDA request for comments on timing for implementation of safety labeling changes
- Sidley Austin LLP
- -
- USA
- -
- January 4 2012
On December 20, 2011, the U.S. Food and Drug Administration (FDA) published a notice requesting public input on the deadlines for implementing drug safety labeling changes
Current Search
- Firm Name - Sidley Austin LLP
- Author - Coleen Klasmeier
Suggested Facets
Author
- Gail H. Javitt (3)
- James C. Stansel (8)
- Jeffrey M. Senger (2)
- Katherine Strong Carner (1)
- Lauren R. Silvis (4)
- Maurits J.F. Lugard (1)
- Paul E. Kalb, M.D (1)
- Raymond A. Bonner (24)
- Scott Bass (14)